Areas of Focus
- 肿瘤药理学和分子药理学
Work Experience
- 2005-2009 - 美国爱默雷大学，癌症研究所 - 博士后，研究助理
- 2009-至今 - 南京医科大学，基础医学院，药理学系 - 教授
Academic Background & Achievements
- 2000-2003 医学博士：中山大学，中山医学院
- 博士后研究：美国莫浩斯医学院，心血管研究所
- 博士后研究：美国爱默雷大学，癌症研究所
Publications
- Sulfonylurea receptor 1-expressing cancer cells induce cancer-associated fibroblasts to promote non-small cell lung cancer progression., Hongling Chen, Li Zhao, Yuting Meng, Xixi Qian, Ya Fan, Quanli Zhang, Chao Wang, Fan Lin, Baoan Chen, Lin Xu, Wenbin Huang, Jing Chen, Xuerong Wang, 2022
- Tumor-derived exosomal miR-19b-3p facilitates M2 macrophage polarization and exosomal LINC00273 secretion to promote lung adenocarcinoma metastasis via Hippo pathway., Jing Chen, Kai Zhang, Yingru Zhi, Yin Wu, Baoan Chen, Jinyu Bai, Xuerong Wang, 2021
- Trichostatin A downregulates bromodomain and extra-terminal proteins to suppress osimertinib resistant non-small cell lung carcinoma., Yuting Meng, Xixi Qian, Li Zhao, Nan Li, Shengjie Wu, Baoan Chen, Tong Sun, Xuerong Wang, 2021
- Glibenclamide targets sulphonylurea receptor 1 to inhibit p70S6K activity and upregulate KLF4 expression to suppress non-small cell lung carcinoma., Kexin Xu, Geng Sun, Min Li, Hongling Chen, Zuhao Zhang, Xixi Qian, Ping Li, Lin Xu, Wenbin Huang, Xuerong Wang, 2019
- Targeting BRD4 proteins suppresses the growth of NSCLC through downregulation of eIF4E expression., Zhongyuan Gao, Ting Yuan, Xiao Zhou, Ping Ni, Geng Sun, Ping Li, Zhixiang Cheng, Xuerong Wang, 2018
